A subscription to JoVE is required to view this content. Sign in or start your free trial.
Hepatocytes derived from pluripotent stem cells can be purified through cell sorting, using a combination of mitochondrial and activated leukocyte cell adhesion molecule (ALCAM, also known as CD166) staining.
Human embryonic stem (ES) and induced pluripotent stem (iPS) cells have potential applications in cell-based regenerative medicine for treating severely diseased organs due to their unlimited proliferation and pluripotent properties. However, differentiating human ES/iPS cells into 100% pure target cell types is challenging due to their high sensitivity to the environment. Tumorigenesis after transplantation is caused by contaminated, proliferating, and undifferentiated cells, making high-purification technology essential for the safe realization of regenerative medicine. To mitigate the risk of tumorigenesis, a high-purification technology has been developed for human iPS cell-derived hepatocytes. The method employs FACS (fluorescence-activated cell sorting) using a combination of high mitochondrial content and the cell-surface marker ALCAM (activated leukocyte cell adhesion molecule) without genetic modification. 97% ± 0.38% (n = 5) of the purified hepatocytes using this method exhibited albumin protein expression. This article aims to provide detailed procedures for this method, as applied to the most current two-dimensional differentiation method for human iPS cells into hepatocytes.
Embryonic and induced pluripotent stem cells (ES and iPS, respectively) are considered promising cell sources for regenerative therapies. However, the efficiency of differentiating these cells into specific target cell types can vary, even when using the same cell line, protocol, and experimenter1,2,3,4. This variability may be attributed to the high sensitivity of human ES/iPS cells to their environment. Therefore, it is currently difficult to consistently obtain pure target cells. To achieve highly safe regenerative medicine, it is crucial....
This study used commercially obtained human iPS cells (253G1 strain) (see Table of Materials).
1. Maintenance of human iPS cells
2. Hepatic differentiation of human iPS cells in 2D cultures
NOTE:.......
The timeline of the processes inducing human iPS cells to differentiate into hepatocytes through 2D culture (Figure 1A) and representative cell features (Figure 1B) are shown. Approximately on differentiation day 12, cells began to exhibit polygonal cell shapes and round nuclei, characteristic of hepatocytes. Some hepatocytes also displayed multinucleation.
FACS analysis was performed using the cells on differentiation day 27. To iden.......
Due to their functions in nutrient metabolism and detoxification, hepatocytes possess a relatively large number of mitochondria compared to other cell types15. ALCAM is a member of the immunoglobulin superfamily and plays a role in cell adhesion and migration. It is expressed in various cell types, including hepatic, epithelial, lymphocytic, myeloid, fibroblast, and neuronal cells16. By utilizing a combination of the mitochondria-based method and the ALCAM antibody, human i.......
This work was supported by the Ministry of Education, Culture, Sports, Science and Technology grant number [23390072].
....Name | Company | Catalog Number | Comments |
253G1 human iPS cell line | RIKEN BioResource Research Center | HPS0002 | |
4% paraformaldehyde | FUJIFILM Wako Pure Chemical Corporation | 163-20145 | |
Activin A Solution, Human, Recombinant | NACALAI TESQUE, INC. | 18585 | |
Anti-Nuclei Antibody, clone 235-1 | Chemicon | MAB1281 | Antibody against human nuclear antigen |
B-27 Supplement (50x), serum free | Thermo Fisher Scientific | 17504044 | |
BD FACSAria III | BD Biosciences | Cell sorter | |
CHIR-99021 | MedChemExpress | HY-10182 | |
Ciclosporin A | FUJIFILM Wako Pure Chemical Corporation | 035-18961 | |
Collagenase | FUJIFILM Wako Pure Chemical Corporation | 034-22363 | |
Corning Matrigel Growth Factor Reduced (GFR) Basement Membrane Matrix | Corning | 354230 | Gel-like basement membrane matrix |
CultureSure Y-27632 | FUJIFILM Wako Pure Chemical Corporation | 036-24023 | ROCK inhibitor |
Dexamethasone | FUJIFILM Wako Pure Chemical Corporation | 047-18863 | |
Dimethyl sulfoxide (DMSO) | FUJIFILM Wako Pure Chemical Corporation | 047-29353 | |
Donkey anti-Goat IgG (H+L) Cross-Adsorbed Secondary Antibody, Alexa Fluor 488 | Thermo Fisher Scientific | A-11055 | |
Donkey anti-Mouse IgG (H+L) Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor 546 | Thermo Fisher Scientific | A10036 | |
Donkey anti-Rabbit IgG (H+L) Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor 488 | Thermo Fisher Scientific | A-21206 | |
Falcon 5 mL Round Bottom Polystyrene Test Tube, with Cell Strainer Snap Cap | Corning | 352235 | |
Fetal Bovine Serum | Biowest | 51820-500 | |
GlutaMAX Supplement | Thermo Fisher Scientific | 35050061 | Dipeptide L-Alanyl-L-Glutamine |
Human/Mouse/Rat/Canine ALCAM/CD166 Antibody | R&D Systems | AF1172 | |
Hydrocortisone 21-hemisuccinate sodium salt | Sigma-Aldrich | H2270 | |
iMatrix-511 silk | Nippi | 892021 | |
ImmunoBlock | KAC | CTKN001 | Blocking solution |
ITS-G Supplement(×100) | FUJIFILM Wako Pure Chemical Corporation | 090-06741 | |
Leibovitz's L-15 Medium | FUJIFILM Wako Pure Chemical Corporation | 128-06075 | |
N-Hexanoic-Try-Ile-(6)-amino Hexanoic amide (Dihexa) | Toronto Research Chemicals | H293745 | |
Polyclonal Rabbit Anti-Human Albumin | Dako | A0001 | |
Polyoxyethylene Sorbitan Monolaurate (Tween 20) | NACALAI TESQUE, INC. | 28353-85 | |
RPMI-1640 | FUJIFILM Wako Pure Chemical Corporation | 189-02025 | |
Sodium L-Ascorbate | NACALAI TESQUE, INC. | 03422-32 | |
StemFit AK02N | REPROCELL | RCAK02N | |
TBS (10x) | NACALAI TESQUE, INC. | 12748-31 | |
Tetramethylrhodamine, methyl ester (TMRM) | Thermo Fisher Scientific | T668 | |
Triton X-100 | NACALAI TESQUE, INC. | 28229-25 | |
Trypan Blue Solution | NACALAI TESQUE, INC. | 20577-34 | |
TRYPSIN 250 | Difco | 215240 | |
Tryptose phosphate broth solution | Sigma-Aldrich | T8159 |
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved